Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

HDL and inflammation in atherosclerosis.

Lukas E Spieker1, Frank Ruschitzka, Thomas F Lüscher

  • 1Cardiology, Cardiovascular Center, University Hospital, Zürich, Switzerland.

Current Drug Targets. Immune, Endocrine and Metabolic Disorders
|March 23, 2004
PubMed
Summary

High-density lipoprotein (HDL) cholesterol offers protective vascular effects, including anti-inflammatory and antioxidant properties. Elevating HDL may be a promising therapeutic strategy for preventing and treating atherosclerotic vascular disease.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pharmacologic and Lifestyle Interventions to Modulate the Epigenome in Heart Failure.

Heart failure clinics·2025
Same author

Transcriptomic and proteomic profiling shows dysregulated immune and metabolic pathways in arrhythmogenic cardiomyopathy.

ESC heart failure·2025
Same author

Unlocking metabolic flexibility in heart failure with preserved ejection fraction: Bridging fundamental mechanisms to clinical innovation.

iScience·2025
Same author

Functional and morphological determinants of left ventricular fibrosis in patients with mitral annular disjunction in cardiac magnetic resonance imaging.

European heart journal. Imaging methods and practice·2025
Same author

Safety and effectiveness of left atrial appendage occlusion in patients with atrial fibrillation and high bleeding risk: a cardinality-matched comparison with direct oral anticoagulation on long-term stroke and bleeding rates.

Swiss medical weekly·2025
Same author

Cardiac amyloidosis in a Swiss autopsy cohort - distribution and clinical relevance.

Swiss medical weekly·2025

Area of Science:

  • Cardiovascular Medicine
  • Biochemistry

Background:

  • Atherosclerotic vascular disease is a leading global cause of mortality.
  • Current treatments focus on lowering low-density lipoprotein (LDL) cholesterol, achieving significant risk reduction.
  • Inflammatory mechanisms are increasingly recognized as critical in vascular disease progression.

Purpose of the Study:

  • To highlight the multifaceted protective roles of high-density lipoprotein (HDL) cholesterol in vascular health.
  • To propose HDL elevation as a novel therapeutic target for atherosclerotic vascular disease.

Main Methods:

  • Review of existing literature on HDL cholesterol's functions and therapeutic potential.
  • Analysis of the correlation between inflammatory markers and cardiovascular disease prognosis.

Related Experiment Videos

Main Results:

  • HDL cholesterol exhibits significant anti-inflammatory and antioxidant effects on the vasculature.
  • HDL possesses antithrombotic and pro-fibrinolytic properties.
  • HDL facilitates reverse cholesterol transport, crucial for preventing plaque buildup.

Conclusions:

  • The pleiotropic beneficial effects of HDL make it an attractive therapeutic target.
  • Strategies aimed at increasing HDL levels hold promise for preventing and treating atherosclerotic vascular disease.